<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In situ hybridisation has been used to detect <z:chebi fb="2" ids="33699">mRNAs</z:chebi> to the macrophage secretory products, lysozyme, interleukin 1 beta and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha </plain></SENT>
<SENT sid="1" pm="."><plain>Sections of <z:chebi fb="0" ids="31962">paraformaldehyde</z:chebi> fixed, frozen colonoscopic biopsies from patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> or <z:mpath ids='MPATH_458'>normal</z:mpath> controls were hybridised with specific radiolabelled probes and the signal detected by autoradiography </plain></SENT>
<SENT sid="2" pm="."><plain>Lysozyme <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was more common in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (22/27) and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (eight of eight) compared with controls (17/27) </plain></SENT>
<SENT sid="3" pm="."><plain>Positive cells were found mainly in the subepithelial region in <z:mpath ids='MPATH_458'>normal</z:mpath> colon, while in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> they also appeared in the deeper lamina propria </plain></SENT>
<SENT sid="4" pm="."><plain>Immunocytochemistry in parallel sections showed that lysozyme <z:chebi fb="2" ids="33699">mRNA</z:chebi> was expressed only in macrophages or in metaplastic Paneth cells in longstanding <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Tissue neutrophils did not express the lysozyme <z:chebi fb="2" ids="33699">mRNA</z:chebi>, though they have large stores of the protein </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor <z:chebi fb="2" ids="33699">mRNA</z:chebi> was detected in four of nine controls compared with 11/15 inflammatory <z:e sem="disease" ids="C0021831" disease_type="Disease or Syndrome" abbrv="">bowel disease</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>For interleukin 1 beta, three of eight controls were positive compared with 10/13 with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor signal was located mainly in the deeper lamina propria whereas the interleukin 1 beta was seen in subepithelial macrophages </plain></SENT>
<SENT sid="9" pm="."><plain>These results confirm increased macrophage activation in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> and suggest functional <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> within the intestinal macrophage population </plain></SENT>
</text></document>